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ABSTRACT
To date, blood banks apply routine diagnosis to a specific spectrum of transfusion-
transmitted viruses. Even though this measure is considered highly efficient to control their 
transmission, the threat imposed by emerging viruses is increasing globally, which can 
impact transfusion safety, especially in the light of the accelerated viral discovery by novel 
sequencing technologies. One of the most important groups of patients, who may indicate 
the presence of emerging viruses in the field of blood transfusion, is the group of individuals 
who receive multiple transfusions due to hereditary hemoglobinopathies. It is possible that 
they harbor unknown or unsuspected parenterally-transmitted viruses. In order to elucidate 
this, nucleic acids from 30 patients with beta-thalassemia were analyzed by Illumina next-
generation sequencing and bioinformatics analysis. Three major viral families: Anelloviridae, 
Flaviviridae and Hepadnaviridae were identified. Among them, anelloviruses were the 
most representative, being detected with high number of reads in all tested samples. Human 
Pegivirus 1 (HPgV-1, or GBV-C), Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) 
were also identified. HBV and HCV detection was expected due to the high seroprevalence 
in patients with beta thalassemia. Our results do not confirm the presence of emerging or 
unsuspected viruses threatening the transfusion safety at present, but can be used to actively 
search for viruses that threaten blood transfusion safety. We believe that the application of 
viral metagenomics in multiple-transfused patients is highly useful to monitor possible viral 
transfusion threats and for the annotation of their virome composition.
KEYWORDS: Metagenomics. Next-generation sequencing. Beta-thalassemia. Virome. 
Hemotherapy. Emerging viruses.
INTRODUCTION
Blood Transfusion Services worldwide apply highly sensitive diagnostic tests to 
detect Human Immunodeficiency virus (HIV), Hepatitis B Virus (HBV), Hepatitis 
C virus (HCV), syphilis, and in some countries Human T-cell lymphotropic virus 
(HTLV) and Chagas disease as well. Therefore, hemotherapeutic procedures 
including blood transfusion are considered safe. Although the transfusion risk of 
transmission of routinely tested viral agents has been dramatically reduced, even 
the most sensitive detection techniques cannot guarantee a “zero risk”. Therefore, 
occasional transfusion transmission of routinely tested agents is observed1 mainly 
due to circulation of novel mutation variants and/or the presence of very low viral 
load levels such as the ones reported in occult HBV infection2,3, HCV4 and HIV5. 
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Apart from the risk of transfusion transmission of 
the routinely tested viruses, there is a risk of parenteral 
transmission of virtually any viral agent that will thereafter 
establish viremia. In this respect, emerging viruses which 
can threaten the safety of blood transfusion are especially 
important. The list of these viral agents is extensive6 and 
includes typical arboviral agents with short-termed viremia 
like dengue (DENV)7,8 and Zika viruses (ZIKV)9 and 
others with prolonged viremic phases like Hepatitis E virus 
(HEV)10,11 and Parvovirus type 4 (PARV4)12. 
Multiple-transfused patients with hereditary 
hemoglobinopathies are at high risk of acquiring 
parenterally-transmitted viruses. Historically, these 
patients demonstrate higher prevalences of HIV, HCV and 
HBV13 compared to the general population. Moreover, due 
to frequent transfusions, one may infer that unsuspected 
viral infections which are not routinely tested in Blood 
Transfusion Services can also be present. 
Considering that it is impossible to test all possible 
infections that can threaten transfusion safety, a suitable 
approach would be the virome examination of multiple 
-transfused patients through metagenomic High Throughput 
Sequencing (mHTS). This approach gives a detailed 
information regarding the overall viral abundance and 
diversity in any type of clinical sample, thus speeding up 
the discovery of emerging viruses14,15. Therefore, the use 
of mHTS for evaluating the virome in patients receiving 
multiple transfusions can provide important information 
on the presence of unsuspected viral infections that can 
threaten blood transfusion. 
The aim of our study was to annotate the virome of 
patients with beta-thalassemia major in order to search for 
viral agents that can threat blood transfusion safety. The 
choice of this group was based on the following reasons: 
(i) Historically, patients with beta thalassemia present 
with higher indexes of transfusion-transmitted diseases, 
which have been reduced nowadays, but continue elevated 
compared to the general population. This demonstrates that 
patients with beta-thalassemia are under a constant threat 
of acquiring parenterally-transmitted infections, especially 
the emerging ones. (ii) Presence of endemic viral diseases 
in the examined region like dengue and Zika infections 
that are transmitted by arthropod vectors but might also be 
transmitted by blood transfusion.
MATERIALS AND METHODS
Study population
In the present study, we evaluated the virome of 
30  patients with beta-thalassemia, who sought medical 
attention at the hemoglobinopathies outpatient clinic of 
the Blood Center of Ribeirao Preto, Faculty of Medicine 
of Ribeirao Preto, University of Sao Paulo. From these 
patients, 20 were male (66.7 %) and 10 were female 
(33.3%) with a mean age of 26.6 years (range 6-47 years). 
The serological screening for the routinely tested viruses 
transmitted by blood transfusion revealed a seroprevalence 
of 23.3% (n=7/30) for anti-HCV IgG and 16.7% of anti-Hbs 
Ag (n=7/30). 
Between September-October, 2018, blood samples were 
collected individually from each patient during monthly 
examinations at the outpatient clinic. All patients included 
in this study were transfusion-dependent and represented 
a total of 73.2% of all thalassemia patients treated in our 
institution. Approximately 6 mL of whole blood were 
collected in a sterile vacutainer tube (Beckton-Dickinson, 
NJ, USA), after individual informed consent. The samples 
were initially centrifuged at low speed for plasma separation 
(1,931 × g, 10 min) and if not immediately processed they 
were stored at -80 °C. The study was approved by the 
Institutional Ethics Committee of the University Hospital 
at the Faculty of Medicine of Ribeirao Preto, University of 
Sao Paulo, Brazil (process Nº HCRP-12196/2018). 
Sample preparation and Illumina sequencing
Initially, 600 μL of plasma obtained from each patient 
were pre-treated with Turbo DNase (Turbo DNA-free kit, 
Thermo Fisher Scientific,Waltham, MA, USA ) in order to 
remove free host/bacterial DNA in the analyzed samples 
(DNAse incubation at 37 °C for 30 min). After DNase 
inactivation, five individual samples were mixed in a single 
pool. The total pool volume (3 mL) was extracted using the 
High Pure Viral Nucleic Acid Large Volume Kit (Roche, 
Sao Paulo, Brazil) following the manufacturer’s instructions 
with minor modifications: the polyA carrier RNA from the 
kit was replaced by the neutral carrier i.e. GenElute Linear 
Polyacrylamide carrier (LPA) (Merck & Co., Kenilworth, 
New Jersey, USA) and Isopropanol was added to the 
Binding buffer before the filtration step. After column 
extraction, viral nucleic acids were submitted to reverse 
transcription using the Superscript III First-Strand Synthesis 
System (ThermoFisher Scientific,Waltham, MA, USA). 
Amplification of synthesized cDNA was performed using 
the QuantiTect Whole Transcriptome Kit (QIAGEN, Hilden, 
Germany). The preparation of libraries for sequencing was 
performed using the Nextera DNA Flex Library Preparation 
Kit (Illumina, San Diego, CA, USA) and the Nextera DNA 
CD Indexes kit following the manufacturer’s instructions. 
The sequencing the dual-indexed libraries was carried out 
with an Illumina NextSeq 550 sequencer using the NextSeq 
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High Output Kit v.2.5, 300 cycles (Illumina, San Diego, 
CA, USA) following the manufacturer’s instructions. The 
sensitivity of viral identification sequencing was evaluated 
using pools containing clinically relevant DNA and RNA 
viral agents with varying levels of viral load, as described 
previously16. 
Bioinformatics processing of the obtained sequencing 
data
Sequence reads were initially processed for quality 
examination using FastQC (v. 0.11.8, Babraham Institute, 
Cambridge, UK). The low-quality reads, sequences with 
ambiguous bases and duplicated reads were removed using 
PRINSEQ (v. 0.20.4, SDSU, San Diego, CA, USA). To 
remove any host-related sequences and to retain as much 
viral sequences as possible, we used DeconSeq (v. 0.4.3, 
SDSU, San Diego, CA, USA). The remaining reads were 
taxonomically analyzed using Kraken (v. 2, Johns Hopkins 
University, Baltimore, MD, USA). The unclassified 
sequences were analyzed using Blastn and Blastx. Assembly 
was performed by SPAdes (v. 3.13.0, St. Petersburg State 
University, CAB, St. Petersburg, Russia). All generated 
contigs were analyzed using Blastn with nucleotide 
database obtained by the NCBI and an E-value cutoff of 
10-3. For protein similarity evaluation, we used DIAMOND 
(v.2.0.6, University of Tübingen, Tübingen, Germany). The 
presence of environmental or other contaminants/possible 
misclassifications was evaluated using the P-DiP pipeline 
as previously established17.
Phylogenetic analysis of the most important viral 
contigs
Phylogenetic analysis of the consensus contigs was 
performed using datasets of complete or partial genomes 
obtained from NCBI (National Center for Biotechnology 
Information). Multiple alignment was performed using 
MAFFT (v.7.450, Kyoto University, Kyoto, Japan) and the 
phylogenetic signal was verified using TREE-PUZZLE 
v. 5.3 (Max-Planck-Institute, Berlin, Germany). The 
reconstruction of the trees was performed with IQ-TREE 
(v. 1.6.8, CIBV, Vienna, Austria) applying the Maximum 
Likelihood method with a statistical support of 10,000 
bootstrap replicates. The phylogenetic trees were visualized 
with FigTree (v. 1.4, IEB, University of Edinburgh, 
Edinburgh, UK). Only bootstrap values of above 75% were 
considered statistically significant and were represented in 
important phylogenetic branches. 
RESULTS
The Illumina sequencing generated a total of 808,427,182 
reads in plasma samples obtained from patients with beta 
thalassemia. We determined an average of 134 million reads 
with nucleotide lengths of 150 bp for each plasma pool 
(range: 119-160×106 reads/pool) (Table 1). After trimming, 
an average of 13.5 x 106 reads (10.48%) were eliminated 
from five pools, while one pool (number 6) showed removal 
of 82 x 106 million reads (50.9% from its total reads). After 
taxonomic classification, the classified sequences (range: 
73-119 x 106 reads/pool) were kept for de novo assembly 
and Blastn/Blastx analysis. On average, viral sequences 
corresponded to 0.023 % of reads per pool (range: 0.002 
to 0.11%). The unclassified sequences corresponded to a 
medium of 5.82 % of the total reads (range: 5.19% - 6.24%). 
From the classified viral sequences, the maximum contig 
length was 3,786 bp and belonged to HCV (start position 
3,441 bp ends 7,158 bp when aligned with the reference 
HCV genome NC_038882. This region encompassed the 
entire NS3, NS4A and NS4B genes, and partially to NS5A 
gene). We observed that ~ 93% of the classified contigs were 
assigned as human sequences. From the known viruses, 
we detected three major viral families: Anelloviridae, 
Flaviviridae and Hepadnaviridae. Most of the viral 
reads corresponded to anelloviruses and were mainly 
assigned to Torque teno virus (TTV) (>  95%) from the 
Alphatorquetenovirus genus, detected in each pool. Other 
Anelloviridae family genus including Gammatorquevirus 
(Torque teno midi virus, TTMDV) and Betatorquevirus 
Table 1 - Workflow of the sequences analysis, from raw data to assignment. 
Pool number Total reads
Reads after 
trimming
Classified reads Viral reads Viral Reads (%)
Unclassified 
reads
Pool 1 126,241,206 112,680,449 106,827,862 2,642 0.002% 5,852,587
Pool 2 140,189,184 120,822,545 113,278,558 141,841 0.11% 7,543,987
Pool 3 123,039,880 109,175,346 102,493,334 26,556 0.02% 6,682,012
Pool 4 119,051,092 107,960,664 101,267,675 3,414 0.003% 6,692,989
Pool 5 139,336,406 128,896,726 119,770,867 3,673 0.003% 7,125,859
Pool 6 160,569,414 78,111,788 73,753,074 3,555 0.002% 4,358,714
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(Torque teno mini virus, TTMV), were also represented 
(1.5-16.7% of all anelloviruses present). Human pegivirus-1 
(HPgV-1, formerly known as GB virus C or Hepatitis G 
virus) was also found in three out of six plasma pools 
with a particularly high number of reads in pool number 2 
(158,790  reads) (Table 2). The performed phylogenetic 
reconstruction of the largest HPgV-1 contig (1,360 bp, 
sequence starting at position 2,228 bp and ending at position 
at 3,554 bp when aligned with HPgV-1 genome NC_001710 
corresponding to the p7-NS2 gene), demonstrated that it 
belongs to genotype 2 (subgenotype 2A) (Figure 1).
We have also detected a large number of sequences 
(1,390 reads) in one of the pools (pool 6, Table 2) 
corresponding to HCV (family Flaviviridae). The detection 
of HCV nucleic acids was related to the presence of HCV 
viremia in one of the samples of the pool (viral load of 
HCV, 56,793 IU/mL). The performed phylogenetic analysis 
of the obtained 3,786 bp contigs demonstrated that it 
belongs to HCV genotype 1A (Figure 1). The established 
bioinformatics pipeline was also able to detect 8 reads 
belonging to HBV (Hepadnaviridae family) in one pool 
(pool 4). The phylogenetic analysis of the obtained HBV 
contigs (244 bp, sequence starting at position 1,610 bp 
and ending at position 1,853 bp aligned with reference 
genome NC_003977.2 and corresponding partially to 
the genomic region of the X protein) demonstrated that it 
belongs to genotype A. The consensus sequences used in the 
phylogenetic analyses were deposited under the following 
Table 2 - Number of reads of the main viral families detected by the applied metagenomic pipeline in plasma samples from patients 
with beta-thalassemia. 
Samples Pool 1 Pool 2 Pool 3 Pool 4 Pool 5 Pool 6
Anelloviridae 1,794 13,126  42,954 4,480 4,081 3,088
Alphatorquevirus 1,724 11,384 41,587 3,912 3,516 3,012
Gamatorquevirus 52 1,232 827 408 313 23
Betatorquevirus 5 251 82 42 132 17
HPgV-1 (GBV-C) - 158,790 5 26 - -
Hepatitis B - - - 8 - -
Hepatitis C - - - - - 1,390
Figure 1 - Phylogenetic trees of the most abundant viruses detected by viral metagenomic analysis in patients with β-thalassemia 
major. The phylogenetic trees were reconstructed using the General Time Reversible (GTR) and Transversion Nucleotide Substitution 
model (TVM) selected by the ModelFinder through Bayesian Information Criteria (BIC), as implemented by IQtree software v. 1.6.2. 
The Maximum-Likelihood method was used for tree topology reconstruction and for statistical support we used 10,000 ultrafast 
bootstrap replicates. Only bootstrap values above 75% were maintained at important tree branches: A) Phylogenetic tree of the 
contig of Human Pegivirus-1, which was classified as subgenotype 2A of the main genotype 2 that is commonly found in patients 
with high risk of parenteral exposure. The GTR+F+R4 nucleotide substitution model was used for tree reconstruction; B) Taxonomic 
classification of the HBV contig, which clustered within genotype A that is widely spread in Brazil. For tree reconstruction the 
TVM+F+I+G4 nucleotide substitution model was used; C) Phylogenetic tree of HCV. The arrow shows the position of the assembled 
contig within the subgenotype 1A of the main HCV genotype 1. For the tree reconstruction, the GTR+F+R5 nucleotide substitution 
model was used. 
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numbers in the NCBI i.e., HCV (MT596912), HPgV-1 
(MT596914) and HBV (MT596913).
DISCUSSION
In this study, performed among chronically transfused 
Brazilian patients with beta-thalassemia, we evaluated their 
virome by mHTS. By applying this approach, we tried to 
identify emerging or unsuspected viral agents which can 
threaten the transfusion safety. The main reasons to perform 
this study are the high-risk of the thalassemic patients to 
acquire parenteral infections and the endemicity of the 
studied region for arboviruses and other tropical infections 
which can be transmitted via blood transfusion18,19. 
In all of the screened pools we found viruses showing 
persistent viremia, thus demonstrating that transmission can 
occur parenterally. Among them, the most abundant were 
the members of the Anelloviridae family, represented by the 
three major genera: Alpha-, Beta- and Gammatorquetenvirus. 
By far, this is the most abundant group of viruses found 
in blood samples analyzed by viral metagenomics20-22. 
The obtained results are in agreement with the fact that 
anelloviruses are characterized by a high level of genome 
diversity and high prevalences in the human population 
which in some cases can reach 100%23,24. Despite the high 
anellovirus prevalence, the way these viruses interact with 
the hosts is not elucidated. 
Another widely distributed virus, which was found by 
the metagenome pipeline was the HPgV-1, showing an 
elevated number of reads in one of the tested pools. Further 
phylogenetic analysis of the major contigs confirmed the 
presence of HPgV-1 genotype 2 (subgenotype 2A), which is 
the most prevalent genotype in Brazil25,26 that is efficiently 
transmitted by blood transfusion. Similar to the anelloviruses, 
HPgV-1 is highly prevalent in different patient groups, 
especially in patients with high parenteral exposure27-30. This 
is in accordance with our findings of a high number of HPgV-
1 contigs detected among patients with beta-thalassemia. 
Our results are similar to data from the literature which 
demonstrated that HPgV-1 and anelloviruses are the most 
commonly found commensal viruses detected in human 
plasma31. In this respect, these commensal viruses were also 
most frequently identified by viral metagenomic approaches 
in blood donations obtained from healthy donors31,32. In 
general, healthy blood donors are a suitable control group 
that can also be used to compare our results in order to 
evaluate the impact of these commensal viruses on blood 
transfusion. Although we did not implement such a control, 
we believe that the composition of the commensal virome 
between patients and donors might be quite similar based on 
similarities obtained from the literature data31,32. 
On the other hand, important parenterally-transmitted 
viruses like HCV and HBV were also identified which 
differs from the normal blood donor virome. The detection 
of HCV reads in one of the tested pools was due to 
the high seroprevalence of anti-HCV IgG in the tested 
group of patients (23.3%). The phylogenetic analysis of 
the largest HCV contig (3,786 bp) demonstrated that it 
belongs to genotype 1A. This finding is in accordance 
with the literature, pointing out that genotype 1A is the 
most prevalent HCV genotype in Brazil33. We also detected 
a few reads belonging to HBV. The HBV contig was 
composed of 244 bp and although relatively small, it was 
further classified as belonging to HBV genotype A, which 
is also a common Brazilian genotype34. The identification 
of few HBV reads probably reflects low viral loads and 
that the sensitivity of the applied sequencing is adequate 
for the identification of low viral load infections. This 
was supported on one hand by our previous studies which 
sensitively identify underrepresented viruses in artificially 
spiked pools16, and on the other by the extraordinary 
deepness of the applied sequencing (around 200 million 
reads for each tested pool) which possibly enabled the 
detection of infections with low viral loads. In addition, 
the obtained results show that the presence of HCV-RNA 
and HBV-DNA in multiple - transfused patients with 
beta-thalassemia major is in accordance with the genotype 
distribution of these two viruses in Brazil, and that the used 
HTS pipeline was capable of determining the presence of 
active viremia of chronic viral infections. 
A shortcoming was that annotated viral sequences 
were not confirmed by direct molecular methods like PCR. 
However, metagenomics has a high diagnostic potential due 
to the correlation between the percentage of viral reads of 
a given virus and its viral load in the examined sample35,36. 
Nevertheless, sequence reads of only highly represented 
agents were taken into account, except for HBV, which was 
previously confirmed by serological analysis. According 
to some authors, metagenomics could be considered even 
superior to direct molecular methods when working with 
highly diverse viral taxa such as the Anellovirus family for 
which exact primer matching and efficient amplification 
are difficult to be achieved36-38.
In this study, we did not characterize the sequence of 
any new virus that can be regarded as an emerging threat 
to multiple-transfused patients with beta-thalassemia. In 
general, the identification of emerging viruses is dependent 
on nucleotide alignments with known viruses and it is 
difficult to taxonomically classify phylogenetically distant 
viral agents20. However, we identified some sequences with 
low nucleotide sequence coverage (20-30%) belonging to 
the Marseilleviridae, Phycodnaviridae and Mimiviridae 
Valença et al.
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families which represent giant viruses some of which 
have been putatively transmitted by blood transfusion39. 
Due to the low percentage of genomic coverage, we 
could not attribute with certainty that these viral agents 
are emerging viruses threatening the transfusion policies 
in Brazil. Therefore, we believe that there is a need for 
improvement of the current bioinformatics approach to be 
able to classify and identify sequences of phylogenetically 
distant viruses40.
CONCLUSION
In conclusion, this study examined the viral landscape 
in patients with beta-thalassemia. We detected only 
known commensal and parenterally-transmitted viruses 
belonging to different viral families in high-risk patients 
with beta-thalassemia major. Our study demonstrates that 
viral metagenomic approaches represent an interesting tool 
for the evaluation of viral diversity in patients subjected 
to multiple transfusions, reinforcing its relevance for the 
discovery of viral agents that can potentially threaten the 
transfusion safety. 
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